Literature DB >> 678179

Corneal complications after closed vitrectomy through the pars plana.

H D Perry, G N Foulks, R A Thoft, F I Tolentino.   

Abstract

A retrospective study of 150 patients who underwent closed vitrectomy through the pars plana evaluated the incidence and character of postoperative corneal complications. Corneal changes developed in 43% of patients. Thirty patients had significant corneal complications, half of which resolved with treatment. Fourteen patients had complications that necessitated corneal surgery or resulted in loss of useful vision. Diabetic patients were at greatest risk for corneal problems, particularly postoperative epithelial defects. Intraoperative lensectomy was the only other factor that increased the corneal complication rate. The importance of early recognition and therapy for corneal changes after vitrectomy becomes apparent.

Entities:  

Mesh:

Year:  1978        PMID: 678179     DOI: 10.1001/archopht.1978.03910060155011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  18 in total

1.  A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.

Authors:  M Nakahara; K Miyata; S Otani; T Miyai; R Nejima; S Yamagami; S Amano
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 2.  Ocular complications of diabetes mellitus.

Authors:  Nihat Sayin; Necip Kara; Gökhan Pekel
Journal:  World J Diabetes       Date:  2015-02-15

3.  Comprehensive Review of the Effects of Diabetes on Ocular Health.

Authors:  Kathryn Skarbez; Yos Priestley; Marcia Hoepf; Steven B Koevary
Journal:  Expert Rev Ophthalmol       Date:  2010-08-01

4.  Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235.

Authors:  H Fujishima; K Tsubota
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

5.  Changes in corneal sensation following 20 and 23 G vitrectomy in diabetic and non-diabetic patients.

Authors:  M M Mahgoub; T A Macky
Journal:  Eye (Lond)       Date:  2014-07-18       Impact factor: 3.775

6.  Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients.

Authors:  Nobuhiko Chikamoto; Tai-Ichiro Chikama; Naoyuki Yamada; Teruo Nishida; Tadashi Ishimitsu; Akira Kamiya
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

7.  Reduced number of hemidesmosomes in the corneal epithelium of diabetics with proliferative vitreoretinopathy.

Authors:  C A Tabatabay; M Bumbacher; B Baumgartner; P M Leuenberger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

Review 8.  Corneal reepithelialization and anti-inflammatory agents.

Authors:  B D Srinivasan
Journal:  Trans Am Ophthalmol Soc       Date:  1982

9.  Development of an instrument for measurement of light scattering at the corneal epithelial basement membrane in diabetic patients.

Authors:  Norihisa Takahashi; Makiko Wakuta; Naoyuki Morishige; Tai-ichiro Chikama; Teruo Nishida; Yasuhiro Sumii
Journal:  Jpn J Ophthalmol       Date:  2007-06-07       Impact factor: 2.447

Review 10.  Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Matthew S Klocek; Ian S Zagon
Journal:  Brain Res Bull       Date:  2009-08-14       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.